Neutrophil Gelatinase-associated Lipocalin (NGAL) Evaluation in Emergency Department (ED) All-Comers
NCT00845741 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 700
Last updated 2011-01-24
Summary
This study is to evaluate the NGAL point of care device as an aid in the early risk assessment of AKI (acute kidney injury)in an All-Comers ED population.
Conditions
Sponsors & Collaborators
-
Abbott RDx Cardiometabolic
lead OTHER
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2009-02-28
- Primary Completion
- 2010-06-30
- Completion
- 2010-08-31
Countries
- Italy
Study Locations
More Related Trials
-
Evaluation of Neutrophil Gelatinase-associated Lipocalin (NGAL) in Early and Evolving Acute Kidney Injury
NCT00445809 ·Status: COMPLETED
-
Plasma Neutrophil Gelatinase Associated Lipocalin Levels During Emergency Management of Rhabdomyolysis
NCT01544231 ·Status: COMPLETED
-
Neutrophil Gelatinase Associated Lipocalin (NGAL) in Urine: Can This Prove to be a Biomarker for Acute Kidney Injury in Patients With Sepsis?
NCT02034240 ·Status: COMPLETED
-
NGAL and Hepcidin Levels in Hemodialysis Patients in Assiut University Hospital
NCT04083664 ·Status: UNKNOWN
-
Acute Kidney Injury in Severe Trauma
NCT03433079 ·Status: COMPLETED
-
Utility of Neutrophil Gelatinase-associated Lipocalin (NGAL) in Predicting Renal Impairment, Further Decompensation and Rehospitalization in Acutely Decompensated and Chronic Heart Failure Patients
NCT00874289 ·Status: COMPLETED
-
NGAL in Prediction of AKI and Patient Outcomes
NCT06691607 ·Status: COMPLETED
-
Utility of NGAL to Diagnose AKI in Critically Ill Children
NCT03034876 ·Status: UNKNOWN
-
Neutrophil Gelatinase-Associated Lipocalin: Biomarker of Acute Kidney Injury After Cardiac Surgery
NCT00594919 ·Status: UNKNOWN
-
Urinary NGAL Acute Kidney Injury After Stored Red Blood Cells Transfusion in Critically Ill Patients.
NCT03560921 ·Status: COMPLETED
-
Study of Accuracy of NGAL, a Renal Injury Biomarker, in Patients With Cirrhosis
NCT02049125 ·Status: UNKNOWN
-
Urinary Neutrophil Gelatinase-Associated Lipocalin (uNGAL) in Invasive Cardiology
NCT01612117 ·Status: COMPLETED
-
Rapid Evaluation of Acute Kidney Injury With NGAL in Acutely Ill Patients in the ICU
NCT01294228 ·Status: COMPLETED
-
Combining CAF, L-FABP and NGAL as a Potentially Diagnostic Model for Acute Kidney Injury.
NCT04555382 ·Status: UNKNOWN
-
Acute Kidney Injury Neutrophil Gelatinase-Associated Lipocalin Evaluation of Symptomatic Heart Failure Study
NCT01291836 ·Status: COMPLETED
-
Neutrophil Gelatinase-associated Lipocalin in Major Abdominal Surgery
NCT05721638 ·Status: COMPLETED
-
NGAL and Renal Resistive Index in the Diagnosis and Prognosis of Sepsis-associated AKI
NCT05374759 ·Status: COMPLETED
-
Optimizing Electronic Alerts for Acute Kidney Injury
NCT02753751 ·Status: COMPLETED ·Phase: NA
-
Early Renal Replacement Therapy and the Outcome of Acute Kidney Injury
NCT01819038 ·Status: COMPLETED ·Phase: NA
-
Neutrophil Gelatinase-associated Lipocalin as a New Biomarker to Detect Acute Kidney Injury in Postoperative Cardiac Surgery
NCT01594788 ·Status: UNKNOWN
-
Role of NGAL and Cystatin C in Prediction of Acute Kidney Injury Covid-19 Infection
NCT04603664 ·Status: COMPLETED
-
Establishment of ProNephro AKI (NGAL) Cut Off Value for Risk Assessment of Moderate to Severe Acute Kidney Injury in Adults
NCT06652100 ·Status: ACTIVE_NOT_RECRUITING
-
Learning Alerts for Acute Kidney Injury
NCT02786277 ·Status: COMPLETED ·Phase: NA
-
Clinical Values of Automated Electronic Alert for Acute Kidney Injury
NCT02793167 ·Status: COMPLETED ·Phase: NA
-
RenalGuard System and Contrast Media
NCT01098032 ·Status: COMPLETED ·Phase: PHASE3